Current representation of endovascular treatment of patients with left main coronary artery disease
| Autor: | A. S Shanoyan, V. Yu Vlasov, F. B. Shukurov, B. A. Rudenko, A. Sh. Akhadova, V. P Mazaev |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
lcsh:Diseases of the circulatory (Cardiovascular) system
medicine.medical_specialty Percutaneous medicine.medical_treatment coronary artery bypass grafting Disease percutaneous coronary interventions lcsh:Diseases of the endocrine glands. Clinical endocrinology angioplasty and stenting Internal medicine Angioplasty Diabetes mellitus medicine cardiovascular diseases lcsh:RC648-665 business.industry Gold standard Stent left main coronary artery disease Evidence-based medicine medicine.disease surgical procedures operative medicine.anatomical_structure lcsh:RC666-701 Cardiology business endovascular methods of treatment Artery |
| Zdroj: | КардиоСоматика, Vol 7, Iss 2, Pp 56-59 (2016) |
| ISSN: | 2658-5707 2221-7185 |
| DOI: | 10.26442/cs45264 |
| Popis: | Coronary artery bypass grafting (CABG) is known as the gold standard treatment of unprotected left main coronary artery (LMCA) disease and has the highest level of evidence in European and American recommendations. However development of endovascular methods of treatment, and first of all decrease of in-stent-restenosis allow us to consider angioplasty and stenting of LMCA as an alternative method to CABG. The comparative world analysis of results of percutaneous coronary interventions and CABG is provided in article. It tells also how efficiency of percutaneous coronary interventions depends on such factors as lesion localization, diabetes, type of drug-eluting stent. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|